BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vanderborght B, Lefere S, Vlierberghe HV, Devisscher L. The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma. Cells 2020;9:E2382. [PMID: 33143149 DOI: 10.3390/cells9112382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bai Y, Hu X, Ren Z, Hisai T, Yusa W, Weng L, Shiba S, Takase T. A phase I pharmacokinetic study of lenvatinib in Chinese patients with unresectable hepatocellular carcinoma. Future Oncol 2022;18:2413-24. [PMID: 35674480 DOI: 10.2217/fon-2022-0229] [Reference Citation Analysis]
2 Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know? JHC 2022;Volume 9:379-87. [DOI: 10.2147/jhc.s364742] [Reference Citation Analysis]
3 Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases 2022; 10(11): 3321-3333 [DOI: 10.12998/wjcc.v10.i11.3321] [Reference Citation Analysis]
4 Ahn M, Shin J, Yang S, Choi W, Jang S, Kang S, Cho S. Metabolite Profiling of a Sargassum micracanthum Methanol Extract with in vitro Efficacy against Human Head and Neck Squamous Cell Carcinoma Aggressiveness. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105386] [Reference Citation Analysis]
5 Yang Z, Suda G, Maehara O, Ohara M, Yoshida S, Hosoda S, Kimura M, Kubo A, Tokuchi Y, Fu Q, Yamada R, Kitagataya T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Sakamoto N. Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma. Cancers (Basel) 2022;14:232. [PMID: 35008398 DOI: 10.3390/cancers14010232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sheng RJ, Dong HH, Li J. Correlation between contrast-enhanced ultrasound parameters and hypoxia inducible factor-1a in hepatocellular carcinoma residual lesions after transcatheter artery chemoembolization. Shijie Huaren Xiaohua Zazhi 2021; 29(24): 1428-1433 [DOI: 10.11569/wcjd.v29.i24.1428] [Reference Citation Analysis]
7 Tian D, Yu Y, Zhang L, Sun J, Jiang W. A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma. Front Med (Lausanne) 2021;8:681388. [PMID: 34568357 DOI: 10.3389/fmed.2021.681388] [Reference Citation Analysis]
8 Zhang HF, Gao X, Wang X, Chen X, Huang Y, Wang L, Xu ZW. The mechanisms of renin-angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures. Biomed Pharmacother 2021;141:111868. [PMID: 34328104 DOI: 10.1016/j.biopha.2021.111868] [Reference Citation Analysis]
9 Xin PL, Jie LF, Cheng Q, Bin DY, Dan CW. Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis. Front Pharmacol 2021;12:655114. [PMID: 34054534 DOI: 10.3389/fphar.2021.655114] [Reference Citation Analysis]
10 Luan F, Liu B, Guo X, Yong W. Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.111618] [Reference Citation Analysis]